Amundi
VCYT icon

Amundi’s Veracyte VCYT Stock Holding History

Amundi’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
23,305
+11,181
+92% +$469K ﹤0.01% 1278
2026
Q1 		$391K Sell
12,124
-116,588
-91% -$4.32M ﹤0.01% 1643
2025
Q4 		$5.42M Sell
128,712
-33,025
-20% -$1.33M ﹤0.01% 1019
2025
Q3 		$5.83M Buy
+161,737
New +$4.64M ﹤0.01% 932
2023
Q3 		– Sell
-3,500
Closed -$87.2K – 2067
2023
Q2 		$87.2K Hold
3,500
– – ﹤0.01% 1801
2023
Q1 		$75.2K Hold
3,500
– – ﹤0.01% 1814
2022
Q4 		$88.3K Buy
+3,500
New +$81.3K ﹤0.01% 1631

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Amundi's VCYT Position: Q2 2026 in Review

Amundi increased its Veracyte (VCYT) stake by 92% in Q2 2026, buying an estimated $469K and bringing the position to 23,305 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

Amundi first reported a position in VCYT in Q4 2022 and has held it in 7 quarters since. The position peaked at $5.83M in Q3 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Amundi held 23,305 shares of Veracyte worth $1.37M as of Q2 2026.
  • Amundi bought 11,181 Veracyte shares in Q2 2026, an estimated $469K.
  • Veracyte made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1278 holding.
  • Amundi first reported a position in Veracyte in Q4 2022 and has held it in 7 quarters since.
  • Amundi's Veracyte position peaked at $5.83M in Q3 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.